The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Epperly Melissa B, since 2020.
This trader's CIK number is 1807359.
At the time of last reporting, Epperly Melissa B, was the Director of Roivant Sciences Ltd.. (stock ticker symbol ROIV).
Also see all insider trading activities at Roivant Sciences Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ZNTL | 0 | $0 | 11,242 | $129,475 | 0 | $0 |
| 2023 | ZNTL | 0 | $0 | 13,333 | $265,820 | 0 | $0 |
| 2022 | ZNTL | 0 | $0 | 18,993 | $960,997 | 0 | $0 |
| 2021 | ZNTL | 9,611 | $499,751 | 35,605 | $1,666,651 | 0 | $0 |
| 2020 | ZNTL | 20,000 | $360,000 | 19,850 | $1,013,881 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ROIV | 0 | $0 | 41,861 | $1,200,573 | 0 | $0 |
1. Zentalis Pharmaceuticals, Inc. (ZNTL)
2. Roivant Sciences Ltd. (ROIV)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-12 | ZNTL | Sale | 2,573 | 11.44 | 29,435 |
| 2024-02-02 | ZNTL | Sale | 8,669 | 11.54 | 100,040 |
| 2023-10-04 | ZNTL | Sale | 5,482 | 19.67 | 107,819 |
| 2023-02-14 | ZNTL | Sale | 5,227 | 19.98 | 104,409 |
| 2023-02-13 | ZNTL | Sale | 2,624 | 20.42 | 53,592 |
| 2022-04-04 | ZNTL | Sale | 17,080 | 50.75 | 866,878 |
| 2022-02-23 | ZNTL | Sale | 1,913 | 49.20 | 94,119 |
| 2021-08-19 | ZNTL | Buy | 8,285 | 52.00 | 430,803 |
| 2021-08-18 | ZNTL | Buy | 1,326 | 52.00 | 68,948 |
| 2021-07-01 | ZNTL | Sale | 3,083 | 51.61 | 159,113 |
| 2021-06-01 | ZNTL | Sale | 3,083 | 54.45 | 167,857 |
| 2021-05-03 | ZNTL | Sale | 3,083 | 58.75 | 181,135 |
| 2021-04-05 | ZNTL | Sale | 17,107 | 44.02 | 753,015 |
| 2021-03-01 | ZNTL | Sale | 3,083 | 41.67 | 128,484 |
| 2021-02-01 | ZNTL | Sale | 3,083 | 37.89 | 116,827 |
| 2021-01-04 | ZNTL | Sale | 3,083 | 51.97 | 160,220 |
| 2020-12-07 | ZNTL | Sale | 6,464 | 52.87 | 341,725 |
| 2020-12-04 | ZNTL | Sale | 7,220 | 50.97 | 367,988 |
| 2020-12-02 | ZNTL | Sale | 3,083 | 51.78 | 159,628 |
| 2020-04-07 | ZNTL | Buy | 20,000 | 18.00 | 360,000 |
| 2020-11-23 | ZNTL | Sale | 3,083 | 46.88 | 144,540 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-16 | ROIV | Sale | 41,861 | 28.68 | 1,200,573 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Epperly Melissa B, (Director of Roivant Sciences Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.